Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0048 | 0.2482 | 1 |
Toxoplasma gondii | kringle domain-containing protein | 0.0053 | 0.2891 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0138 | 1 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0138 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0603 | 0.0603 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0026 | 0.0603 | 0.0603 |
Toxoplasma gondii | cathepsin B | 0.0048 | 0.2482 | 0.8212 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Leishmania major | hypothetical protein, conserved | 0.0053 | 0.2891 | 1 |
Loa Loa (eye worm) | fibroinase | 0.0026 | 0.0603 | 0.0603 |
Onchocerca volvulus | Cathepsin L homolog | 0.0026 | 0.0603 | 0.2086 |
Brugia malayi | Papain family cysteine protease containing protein | 0.0026 | 0.0603 | 0.0603 |
Giardia lamblia | Cathepsin B precursor | 0.0048 | 0.2482 | 0.5 |
Loa Loa (eye worm) | cysteine protease | 0.0026 | 0.0603 | 0.0603 |
Echinococcus granulosus | cathepsin b | 0.0138 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0048 | 0.2482 | 0.2482 |
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Onchocerca volvulus | 0.0053 | 0.2891 | 1 | |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0048 | 0.2482 | 1 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0138 | 1 | 1 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Loa Loa (eye worm) | ctsf protein | 0.0026 | 0.0603 | 0.0603 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0138 | 1 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0048 | 0.2482 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Brugia malayi | Protein kinase domain containing protein | 0.0053 | 0.2891 | 0.2891 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 1 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0048 | 0.2482 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0053 | 0.2891 | 0.2891 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0053 | 0.2891 | 0.2891 |
Onchocerca volvulus | Cathepsin F homolog | 0.0026 | 0.0603 | 0.2086 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trypanosoma cruzi | cruzipain precursor, putative | 0.0026 | 0.0603 | 0.0603 |
Schistosoma mansoni | hypothetical protein | 0.0053 | 0.2891 | 0.2891 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0138 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Echinococcus granulosus | cathepsin L cysteine proteinase | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Loa Loa (eye worm) | cathepsin B | 0.0048 | 0.2482 | 0.2482 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L or K-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0053 | 0.2891 | 0.2435 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0053 | 0.2891 | 0.2891 |
Echinococcus granulosus | cathepsin l cysteine peptidase | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0048 | 0.2482 | 0.8212 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0138 | 1 | 1 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0026 | 0.0603 | 1 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0026 | 0.0603 | 0.0603 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0053 | 0.2891 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Echinococcus granulosus | cathepsin b | 0.0138 | 1 | 1 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0138 | 1 | 1 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Echinococcus granulosus | cathepsin l1 | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Loa Loa (eye worm) | Papain cysteine protease/cathepsin propeptide inhibitor-containing protein | 0.0026 | 0.0603 | 0.0603 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.2891 | 0.2891 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Onchocerca volvulus | Cathepsin L homolog | 0.0026 | 0.0603 | 0.2086 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0026 | 0.0603 | 1 |
Brugia malayi | Kringle domain containing protein | 0.0053 | 0.2891 | 0.2891 |
Brugia malayi | Cathepsin L-like precursor | 0.0026 | 0.0603 | 0.0603 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0048 | 0.2482 | 0.2482 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0053 | 0.2891 | 1 |
Entamoeba histolytica | cysteine protease, putative | 0.0026 | 0.0603 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Trichomonas vaginalis | Clan CA, family C1, papain-like cysteine peptidase | 0.0026 | 0.0603 | 0.243 |
Onchocerca volvulus | 0.0026 | 0.0603 | 0.2086 | |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0026 | 0.0603 | 0.0603 |
Loa Loa (eye worm) | papain family cysteine protease containing protein | 0.0026 | 0.0603 | 0.0603 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MST (functional) | day | Antimalarial effect of the compound was measured against trophozoite induced P. berghei in mice at dosage of 40 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
MST (functional) | day | Antimalarial effect of the compound was measured against trophozoite induced P. berghei in mice at dosage of 160 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
MST (functional) | ND 0 day | Antimalarial effect measured against trophozoite induced P. berghei in mice at dosage of 640 mg/kg after sc administration | ChEMBL. | 7009867 |
MST (functional) | ND 0 day | Antimalarial effect measured in trophozoite induced P. berghei mice at dose of 320 mg/kg after sc administration. | ChEMBL. | 7009867 |
MST (functional) | 0 day | Antimalarial effect of the compound was measured against trophozoite induced P. berghei in mice at dosage of 160 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
MST (functional) | 0 day | Antimalarial effect measured against trophozoite induced Plasmodium berghei in mice at dosage of 80 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
MST (functional) | 0 day | Antimalarial effect of the compound was measured against trophozoite induced P. berghei in mice at dosage of 40 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
MST (functional) | 0 day | Antimalarial effect measured against trophozoite induced P. berghei in mice at dosage of 20 mg/kg after sc administration; no data | ChEMBL. | 7009867 |
Ratio (functional) | < 2.2 | The ratio of SD90 of the quinine hydrocloride, to the SD90 of the test substance for the Dose of >34 mg/kg | ChEMBL. | 7009867 |
SD90 (functional) | > 34 mg kg-1 day-1 | Antimalarial effect against trophozoite-induced Plasmodium berghei in mice. | ChEMBL. | 7009867 |
SD90 (functional) | > 34 mg kg-1 day-1 | Antimalarial effect against trophozoite-induced Plasmodium berghei in mice. | ChEMBL. | 7009867 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.